Page last updated: 2024-09-03

ly 243670 and enkephalin, ala(2)-mephe(4)-gly(5)-

ly 243670 has been researched along with enkephalin, ala(2)-mephe(4)-gly(5)- in 1 studies

Compound Research Comparison

Studies
(ly 243670)
Trials
(ly 243670)
Recent Studies (post-2010)
(ly 243670)
Studies
(enkephalin, ala(2)-mephe(4)-gly(5)-)
Trials
(enkephalin, ala(2)-mephe(4)-gly(5)-)
Recent Studies (post-2010) (enkephalin, ala(2)-mephe(4)-gly(5)-)
14022,7271374

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Emmerson, PJ; McKinzie, JH; Mitch, CH; Statnick, MA; Surface, PL; Suter, TM1

Other Studies

1 other study(ies) available for ly 243670 and enkephalin, ala(2)-mephe(4)-gly(5)-

ArticleYear
Na+ modulation, inverse agonism, and anorectic potency of 4-phenylpiperidine opioid antagonists.
    European journal of pharmacology, 2004, Jun-28, Volume: 494, Issue:2-3

    Topics: Animals; Appetite Depressants; Binding, Competitive; Cell Membrane; CHO Cells; Cricetinae; Cyclohexanes; Diprenorphine; Dose-Response Relationship, Drug; Eating; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Guanosine 5'-O-(3-Thiotriphosphate); Ligands; Naltrexone; Narcotic Antagonists; Piperidines; Radioligand Assay; Rats; Rats, Zucker; Receptors, Opioid; Receptors, Opioid, delta; Sodium

2004